Statistics from trials show that Can-C™ eye-drops, applied for six months twice daily into the eye, in patients suffering from cataracts resulted in the following:
• 88.9 per cent showed improved glare sensitivity;
• 41.5 per cent had an improvement in the transmissivity of the lens;
• 90 per cent experienced improved visual acuity/sharpness of vision.
In the clinical trials, people who had senile cataracts for less than seven years experienced the fastest and greatest results. People whod had cataracts for seven to 15 years still had good results, but as is usual with most treatments, the earlier Can-C™ is started, the better the results.
